XORTX Therapeutics (XRTX) - 2023 Q2 - Quarterly Report

Exhibit 99.1 XORTX THERAPEUTICS INC. Report of Voting Results (Section 11.3 of National Instrument 51-102) In accordance with section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations, this report briefly describes the matters voted upon and the outcome of the votes at the Annual General and Special Meeting of Shareholders of XORTX Therapeutics Inc. (the "Company") held on June 28, 2023 at the offices of the Company (the "Meeting"). 1. Election of Directors The shareholders voted by way ...